MoonLake Immunotherapeutics
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | -91.7% | +693.6% | +585.2% | -9.2% | -11.2% | |
| – | +495.2% | +694.0% | +572.0% | -7.8% | -11.1% | |
| – | +501.7% | +391.4% | +1,042.0% | -60.0% | +85.4% | |
| – | +501.7% | +797.1% | +608.6% | -12.3% | -12.1% | |
| – | – | +45.9% | +386.7% | +169.0% | +71.3% | |
| – | – | – | – | – | – | |
| – | – | +8.0% | – | – | – | |
| – | +413.9% | -62.1% | +61.6% | +88.1% | +388.8% | |
| – | +16,745.6% | -63.6% | +30.0% | +125.4% | +102.4% | |
| – | +25,734.0% | -99.0% | +679.7% | +14.5% | -10.1% | |
| – | – | -96.1% | +2,985.3% | +492.4% | +227.5% | |
| – | – | – | – | – | – | |
| – | -110.4% | – | +913.7% | -9.9% | -31.9% | |
| – | – | – | – | – | – | |
| – | +149.4% | -20.5% | +67.3% | +28.0% | +2.5% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.